secwatch.observer — SEC 8-K summary
======================================

Issuer:     Serina Therapeutics, Inc. (SER)
CIK:        0001708599
Form:       8-K
Filed at:   2026-06-24T20:10:12+00:00
Accession:  0001708599-26-000040
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Serina increases authorized common stock from 40M to 125M; equity plan expanded by 2M shares
--------------------------------------------------------------------------------

- Authorized common stock increased from 40,000,000 to 125,000,000 shares via filed certificate of amendment.
- 2024 Equity Incentive Plan share reserve raised by 2,000,000 shares to 5,210,478; evergreen start moved to FY2027.
- Stockholders approved all eight proposals at annual meeting, including director elections and share increase.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/0001708599-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1708599/000170859926000040/ser-20260617.htm
  HTML page:      https://secwatch.observer/filing/0001708599-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer